Molecular Modeling of the Toxoplasma Gondii Adenosine Kinase Inhibitors

2024/10/21 by Zandi Asadabadi, Taraneh
#ADME properties #Adenosine Kinase #Drug Design #QSAR modeling #Toxoplasma gondii

paper · doi:10.71886/bioem.2022.1001659

Abstract

Biotechnological Journal of Environmental Microbiology,1(1),1

Related

• The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug design
• Furanocarboxamide Derivative Against Congenital Toxoplasmosis: Synthesis, Bioactivity, ADME Profile and in silico Insights
• Toxoplasma gondii as a drug for anti-tumor immunotherapy: mechanisms, challenges, and perspectives
• Screening the MMV Pathogen Box reveals the mitochondrial bc1-complex as a drug target in mature Toxoplasma gondii bradyzoites
• Ultrastructural Effects of Diclazuril against Toxoplasma gondii and Investigation of a Diclazuril-Resistant Mutant